Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 190

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 190
---
 tax position
taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than
not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals
or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized
upon ultimate settlement. As of December 31, 2024 no liability for unrecognized tax benefits was recorded as a result of the implementation
of ASC 740

<div align='center'>F-12</div>

REVIUM RX.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Cont.)

| l. | Concentrations of credit risk: |

Financial instruments
that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. Cash and cash
equivalents are invested in major banks in Israel.

Management
believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, minimal credit
risk exists with respect to these investments.

| m. | Fair value of financial instruments: |

ASC 820, “Fair
Value Measurements and Disclosures” (“ASC 820”), defines fair value as the price that would be received to sell an asset
or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement
date.

In determining
fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that
maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used
when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market
data obtained from sources independent of the Company.

Unobservable
inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset
or liability developed based on the best information available in the circumstances.

The hierarchy
is broken down into three levels based on the inputs as follows:

| Level 1 | - | Valuations based on quoted prices in active markets for identical assets that the Company has the ability 
 to access.                                                                                                |

| Level 2 | - | Valuations based on one or more quoted prices in markets that are not